Amgen Inc vs Johnson & Johnson
AMGN vs JNJ — side-by-side comparison from reported financials. AMGN leads 8, JNJ leads 3 of 11 comparable metrics.
Amgen Inc
AMGN · Healthcare
$415.01+1.86%Mixed
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | AMGN | JNJ |
|---|---|---|
| Price | $415.01 | $261.79 |
| Market cap | $224B | $631B |
| Revenue (TTM) | $38.1B | $97.9B |
| Revenue growth | +11.8% | +5.6% |
| Net margin | 23.0% | 21.5% |
| Free cash flow | $10.2B | $22.2B |
| Net cash (debt) | ($40.9B) | ($27.8B) |
| 1-year price return | +40.5% | +37.0% |
| P/E | 25.7 | 29.9 |
| P/E vs own history (cheap-side %) | 35% | 16% |
| Dividend yield | 2.32% | 2.00% |
| Return on equity | 89% | 26% |
| Altman Z-score | 1.81 | — |
| CV checks passed | 11 of 11 | 10 of 11 |
| Employees | 31,500 | 140,800 |
Full résumé-style profiles: AMGN CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.